Webinars

View the latest webinars GaBI organized:

BIOSIMILAR RED TAPE ELIMINATION ACT (S2305): Weakening FDA Regulatory Standards for Biosimilars, Undermining Physician Confidence and Jeopardizing Patient Health, 31 October 2024

• ‘the speakers’ presentation is available here

INTERCHANGEABILITY DESIGNATION FOR BIOSIMILARS: Ensuring Continuity of Patient Care: Upholding Interchangeability Status for Biosimilars, 30 November 2023

• ‘contact us for the webinar speakers’ presentations

MEDICARE DRUG PRICE NEGOTIATIONS: impact on healthcare development and patient access to medicines, 26 July 2023

• the meeting report is available here

• ‘contact us for the webinar speakers’ presentations

NON-MEDICAL SWITCHING OF BIOLOGICALS/BIOSIMILARS: CANADA, EUROPE AND THE US, 20 July 2022

• the meeting report is available here

KEY FACTORS FOR SUCCESSFUL UPTAKE OF BIOSIMILARS: EUROPE AND THE US, 29 June 2022

• the meeting report is available here

Last update: 17/03/2025

Go Back

🖨️ Print